ScreenerHero
NNGNanoGroup S.A.
GPW · PL · Healthcare · Biotechnology · nanogroup.eu
2.465PLN-1.20%Mkt Cap: 26.61M $P/E: —

NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap26.61M $
Enterprise Value24.00M $
Revenue (TTM)2.03K $
Gross Profit-93.80K $
Net Income (TTM)-2.39M $
Revenue/Share—
Last Price2.465 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLNNGRP00011
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.80
EV/Revenue11847.67
P/S13241.63
P/B3.42
EPS (TTM)-0.29
EPS (Forward)—
52W Range
2.17528% of range3.200
52W High3.200 PLN
52W Low2.175 PLN
Profitability
Gross Margin2387.50%
Oper. Margin-28412.50%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-108.69%
ROA-23.29%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.23M $
CapEx (TTM)3.74M $
FCF Margin-153677.23%
FCF Yield-11.70%
Net Debt-3.07M $
Net Debt/EBITDA1.25
Balance Sheet
Debt/Equity0.00
Current Ratio11.43
Quick Ratio10.65
Book Value/Sh0.7260 PLN
Cash/Share0.2840 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.42.63M
Float16.24M
Insiders30.12%
Institutions1.64%
Technical
SMA 502.433 (+1.3%)
SMA 2002.530 (-2.6%)
Beta0.54
S&P 52W Chg18.16%
Avg Vol (30d)29.80K
Avg Vol (10d)16.57K
Technical Indicators
RSI (14)55.3
MACD0.0076
MACD Signal0.0028
MACD Hist.+0.0048
BB Upper2.528 PLN
BB Middle2.451 PLN
BB Lower2.375 PLN
BB Width6.28%
ATR (14)0.0737 PLN
Vol Ratio (20d)0.29x